From: Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice
D0
D3
D6
D9
WT
genotype
SP-D -/-
wild-type
treatment
PBS
rfhSP-D
-
Number of animals
5
4
age at first application (weeks)
3
9
6
duration of treatment (weeks)